{"name":"HI-Bio, A Biogen Company","slug":"hi-bio-a-biogen-company","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQVll0dml1NGViZVZKR2k1MTRaSjdmTi1tMi13REN6SlQzWE5fZ2VMMk85ODRkQlFXVl9LYy1TRFgzVzRXcTd2UWRNUVBILS1TRHo1cDRhSGJTZkV0RkFITjdTcVBzNVRWRXUxWnJmLUdubm9vVUlLTlJZSDEtLXk5RFl0YXhwYms?oc=5","date":"2026-04-02","type":"deal","source":"MedCity News","summary":"Why Biogen Is Paying $5.6B to Buy Apellis Pharma - MedCity News","headline":"Why Biogen Is Paying $5.6B to Buy Apellis Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNbDJ3LUVwWFVocHdXak83eTYtd0N3YjNYZE1kNmI1NjFkRDlubkhGQkhweW1tZ1o0aTVhTGZOU295LU5xblJnTHZWWnE1c1FNSnVlMTMyTGl2V3hBRDRjTkstTC03S2hsX2c5V3h5QVhnY012YnBuMV9jclFfUXZlVmRlQXczdkVqc3pMbDV3Qm9ZSlowTTNlU0dmei16QUhaYlpTVQ?oc=5","date":"2026-03-31","type":"deal","source":"BioSpace","summary":"Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy - BioSpace","headline":"Biogen Secures ‘Running Start’ in Kidney Disease With $5.6B Apellis Buy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQU1dqcmZ2ZkFWMGU2WVlXUmtKVUNHbUVDa05VYmJOaE51TW42MlJQS05uaHRMWHZ3MTU0Q1lMUklfY2pfemYzUGUzVWhCNGhkd08yc2FLMFNNUElxTWlkSlhZSVV3NG9EMll1VnBtTFRVLWFVTGxPT2tpckR4U0dJLS1WSXMxX05fbkg3ckIxOFBpR01VbGd0bFAySExQRVA5VlZiMnNlQUNzNmN5Um1RSFhVQ25Xam5N?oc=5","date":"2025-11-24","type":"deal","source":"BioPharma Dive","summary":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio - BioPharma Dive","headline":"Biogen strikes deal with Versant-backed biotech to expand immune portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQUXpROVFhWnYyUWhOaDVVUEIyNDFlaUg2bXZCMGdBR0lkODVBMzlZODlreTNESC1kUHZoR29MMEhEX3FhLUdlUkM1QXlTaVk3OUhGS0loZzdKU1cwQmZrQlhwcDNzRURRelFKVUd2TTFVTU5mQldWTzhmLVUxTUtnT3lnQkZHUTAyc1JHOVdZVGZfak5wZG1EMTc2OGlOZzQ?oc=5","date":"2025-11-18","type":"pipeline","source":"Fierce Biotech","summary":"How Biogen is returning to its roots with a West Coast immunology outpost - Fierce Biotech","headline":"How Biogen is returning to its roots with a West Coast immunology outpost","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNaFFmOTlkQl9vcW9BVzJsdnVtM2Q0YkVsbEFacnRqWHBUN2pVX3pMNXFPV3JYSkdjWmNON0NxbXJfQmVpQnNJbWJFNlZfOHdDbjdaNThjbGNnejBESmYwU2UyVlQ3TnFZaDY3eDdJVEpwSlNySDBkOURkSnlPWV9Fc01BZ0Z0d0RQUEVTZ2gyVFJvbWJ5bGNTWF9RaWhsRDBuX3V3OUhfNTdpQTlzc2xOOG40QzU0dlU?oc=5","date":"2025-10-24","type":"deal","source":"Fierce Biotech","summary":"Biogen beefs up immunology pipeline with $1B deal for Vanqua's preclinical C5aR1 antagonist - Fierce Biotech","headline":"Biogen beefs up immunology pipeline with $1B deal for Vanqua's preclinical C5aR1 antagonist","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNaEhqZnU3N1RwV2VEMkFfTzNaSWFzdlF6R094SHBIM0VHQmtKUUhDRXBVT1hoczhtSnd4Zk5HbUtxOVAyT3Q0bUhHaHVPRVctUjVpMXQ5eUtrQ0JTVjBTVkwwSHI0ZkJ6RGNTWGp1V2ZHcUctUFN1OWk3X2pVeDVXbUZ5ZUZmYU1lS3poWnVwMUhudlh6Q1FzUXQzeXM?oc=5","date":"2025-10-24","type":"deal","source":"BioPharma Dive","summary":"Biogen licenses a possible immune drug from OrbiMed-backed biotech - BioPharma Dive","headline":"Biogen licenses a possible immune drug from OrbiMed-backed biotech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNdFNyUjFhUW9VNHlTSHVLSGdwQ1lRdm9zX1l4TklsZXhkV1JQUzRHM0JsdFlIb2dWdmV2dDBPQ2JVeHVwQmkxb0cyRzVsYmFhUkYyYy04WmpBVk1pdTlIMXNQSWtKLVFGSHR1U0doMzJiSXNaeDViT0w4Z1VJbXJEdEVXZ1ViTnRfSnhRUzdJNnRDdEZXeFluR1Q2dDctZnlfSERNd3VOazVmY21veUFHNkhn?oc=5","date":"2025-09-05","type":"pipeline","source":"Fierce Biotech","summary":"Led by ex-HI-Bio CEO, Braveheart pays $65M to challenge BMS for heart disease market - Fierce Biotech","headline":"Led by ex-HI-Bio CEO, Braveheart pays $65M to challenge BMS for heart disease market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQYTBMX2hPdkRXVXBfSTRpT3kyRlJ5WVNXdloyS1hoZDJxcGhTakRsRGhJMXc1eVVRWnloMmRNWnZtYm96SlN5cHFnU1Rad3BnT0RDclB5elBqRE4tNEM1aUI3N3pIUHJranFDTnJZZDVWRzNoUXZoY0N3aHRjUVFlY2Y2bmE5ZHVmczdJUFE3aFFkY2RidE10eUZ6cW9mRGk4M1dXUlBnNVpsWDM1bXc?oc=5","date":"2025-05-07","type":"pipeline","source":"bizjournals.com","summary":"After big acquisition, Biogen looks to set up West Coast hub in South San Francisco - bizjournals.com","headline":"After big acquisition, Biogen looks to set up West Coast hub in South San Francisco","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNUlNVa2JDaGM1X2xyWW1hc3RFUUZzYXVLNmZQN3dYMk9raktYeUNkVDB2c3dmTXlsck5DLWp5UWlJdGEwN21JV1g2cVJnVk0ycTNveFVrTHJfSGphOUUxRWZBRW1IMnB2Vm5lcW5xejU1MFJsaENGRDZtdEZ5M3ZCQWg2N0pZbWhBSlVwTXZNdjBMSlRKSWV0LUlnenZnb1dia1dYQ3JJLS05aXk3U180WGdBZng0NlBVeElRRw?oc=5","date":"2024-07-03","type":"pipeline","source":"Pharmaceutical Technology","summary":"Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence - Pharmaceutical Technology","headline":"Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxPdmNJYVB3TlY3SU9oTzB3N1hLUEpxSGxLUXF2YzdYZURrcy1nOFJIeUg0Rk8xZG1NQkJWTWdVMVA1aWw3OGRTX0tiaEJ1SW1pZHhtRXphNEZhaV8tUjFvaXBlQUNFM1E1NHc5NkN5SVRpd1FIdDYtNG50cnh4UlNtNFJpR3R6Nl9DRGdPNQ?oc=5","date":"2024-07-03","type":"pipeline","source":"Contract Pharma","summary":"Biogen Completes Acquisition of HI-Bio - Contract Pharma","headline":"Biogen Completes Acquisition of HI-Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNMnZPN3RxV3FHblJySkNBQ255bFUxZGlocGp2QWwzZ3VVaktIaHRWUDZ6ZXhQR0ZyX0lweTh1UTRIWmNDMENGVVdkY180dEdDOUJscEpUQ283bWlUNWRnWExfeTRXQ05zSlVjOVdvMy1JTFVKM1JKM3JQcFR4aTZ0X0w2STk5eGg3MHBKY3NRLUZwOHYtMndtd2NJa2xjMGVxWjZzS21VT0RJWVltMVB4MTk0QXp5YzNtcVhWbHBB?oc=5","date":"2024-07-02","type":"pipeline","source":"Biogen","summary":"Biogen Completes Acquisition of Human Immunology Biosciences - Biogen","headline":"Biogen Completes Acquisition of Human Immunology Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNODg4c1hDVWJ0SER3N1RSTXlyN09JbUJLODRhN1FxMGJmeFRwQTQ1TGo2YTlrZHcwaWQtQ21HR3VwZ3RKSFBiVktfUjhPR0sxOFhzWTJ3WmlXaVZvUEx1cUR5V1VhMXBCYWtocGU5QnFGN3MxY1h0N1QwRlZYbU9od2FwUWNmaEg1UWgyMUk4U1lZaVFtZlNwcDZmYW1QaE93bUNLMXBZeFZDOF9lVHF1al9tRW5weFcwcUFpVmZyZ1hqUFZ0eEVV?oc=5","date":"2024-05-22","type":"deal","source":"Biogen","summary":"Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences - Biogen","headline":"Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}